We report our preliminary experience in five cases of carotid stenting and angioplasty performed under cerebral protection with new filter devices allowing carotid flow maintenance during the procedure. In four out of five cases solid material was found inside the filters after balloon inflation for angioplasty. The technical aspects are discussed with correlation to carotid plaque embolic behavior and to functional factors.
Introduction
Carotid endarterectomy (CEA has proved its efficacy with good long-term results and superiority over medical management for treatment of symptomatic and asymptomatic stenotic lesions of the internal carotid artery (ICA) 1,2,3. On the other hand, treatment of carotid stenosis by angioplasty and stenting have been considered since their introduction a promising and low invasive method when compared with endarterectomy, since they eliminate several surgical drawbacks 4,1,5. However, even if percutaneous techniques have the potential for being safer, less traumatic and more cost-effective, several unresolved issues have prevented their wide acceptance, the main one being the risk of brain embolization 6. The importance of intraprocedural cerebral protection was early recognized by J. Theron, who developed a technique to perform carotid balloon angioplasty under protection by means of a triple-coaxial system and occlusion of the ICA by a non-detachable latex balloon 7, 8, 9 with a significant decrease in embolic complications. Several other authors described techniques for brain protection during angioplasty, all including the need for carotid occlusion for a variable time 10,11. However, until recently, protection devices remained advocated only by a few and there were reports of more complications with protection than without 12 , and the most frequent technical choice of different authors is that of a primary stenting without protection 13,14,12. This was our technical choice four years ago, when we started a new study based on the use of a self-expandable stent; since then we have treated 75 carotid cervical bifurcation stenotic lesions. However, in our recent experience we observed one major stroke from middle cerebral artery embolization by atherosclerotic ma-terial migration caused by balloon inflation after the stent was deployed without any problem. Since then we have modified our approach and we have been looking for a safe protection device. First we tried a new system needing balloon ICA occlusion, the GuardWire (PercuSurge), that we used in seven cases. Only recently have filter protection systems been developed and tested in ex vivo models 15 ; thereafter the filters became available on the market. We describe the first five cases of internal carotid angioplasty and stenting with brain protection obtained with new intracarotid protection filters.
Methods
All the procedures were performed with primary stenting by positioning a Carotid Wallstent (Boston Scientific) across the internal carotid bifurcation and subsequent balloon angioplasty of the residual stenosis; both phases of the procedures were performed under protection of the "emboli capture/brain protection" Angioguard system (Cordis -Johnson & Johnson) in four cases and of the Neuroshield system (MedNova) in one case. Routinely we use stents and balloons built in a monorail architecture; however the new filters are so far available only in double-length for an over-thewire approach.
The Angioguard is a 0.014" steerable guidewire with a distal basket-shaped device acting as a filter: this is composed of a thin polyurethane membrane with microholes (100 microns in diameter), useful for the capture of embolic particles ranging in size from 8 to 3427 microns. It is positioned like a guidewire with a standard technique for crossing the stenosis and subsequent positioning in the distal ICA. The membrane is mounted on four nitinol arms and acts like an "umbrella" after its self-opening following retrieval of the covering sheath. The filter is at the moment available in five nominal sizes ranging from 4.0 to 8.0 mm for the open device. We used a 5.0 mm Angioguard (suitable for 3.5 to 4.5 mm diameter vessels) in three patients and a 6 mm device (suitable for 4.5 to 5.5 mm diameter vessels) in one patient. The French size of all the devices in the closed configuration crossing the stenosis like a guidewire is 4.5 F.
The Neuroshield is a filter device with an in-sertion profile ranging from 4.5 to 5 Fusing similar basic protection principles (guidewirecatheter-membrane filter complex plus retrieval catheter); the guidewire is 0.014" in diameter while the filter is designed as an elongated membranous capsule with four triangular inlet holes and several distal protection microholes; its expansion system is built in nitinol too. The retrieval system is a catheter with a soft and expandable tip that ensures a total coverage of the filter and plaque debris before withdrawal. The filter diameter available is from 4.0 mm to 6.0 mm (in 0.5 mm steps) with a corresponding vessel size range from 3.5-4.2 to 5.7-6.2 mm. In all cases, the endovascular treatment was performed by femoral approach, under local anaesthesia and mild sedation, always maintaining verbal contact and neurologic surveillance of the patient.
Patients received ticlopidine (250 mg twice daily) and aspirin (100 mg twice daily) for 48 hours before the procedure. During the procedure, heparin was always administered to achieve an activated clotting time of at least two and a half times the baseline. One mg atropine was administered just before balloon dilation of the stenosis for possible bradycardia due to carotid glomus stimulation. Blood pressure and neurological status were carefully monitored throughout the procedure.
The filters were kept expanded in the distal ICA until stenting and angioplasty were completed and the inherent devices removed. Thereafter the specific capture sheath was coaxially introduced over the filter wire, allowing at the same time the system to close and embolic debris being trapped inside its lumen with subsequent safe retrieval of the sheath-filter with emboli-guidewire complex.
The four patients treated with protection by means of the AngioGuard system had an atherosclerotic carotid bifurcation lesion with an ICA stenosis of more than 70%, while in the fifth additional case treated with use of the Neuroshield filter a post-radiation 70% stenosis of the distal common carotid artery was present in a patient with contralateral ICA occlusion. In this case, the inner surface of the artery was also severely ulcerated, clearly owing to superimposed atherosclerotic degeneration (figure 1).
All the patients were symptomatic and were well informed about the general risks of the procedure and about the use of a new device and all gave written consent.
Results
In all cases, crossing of the stenosis and positioning of the filtering basket in the distal leA were fast and easy, thanks to the good shapebility and torque ability of both the Angioguard and N euroshield devices. Friction on the plaque surface seemed to be low with a safe "feeling" to the operators. Also the support provided by the main wire body of the devices to the catheter systems carrying the stent and the balloon was good with no need for dangerous tractions on the filter basket already positioned in the leA. The blood flow through the filter immediately after positioning never showed aspects of macroscopic slowing at fluoroscopy, allowing the operators to easily perform the subsequent phases of the procedure with no need for risky haste.
In all cases, we observed a mild degree of leA spasm after filter positioning. Anecdotally, we report that the spasm was somewhat more intense in the Neuroshield case; however, the spasm did not determine a perceivable slowing of the flow and it rapidly regressed after retrieval of the filter without drug administration.
In one case, the filter was completely empty after retrieval. In two cases (including the Neuroshield one) a thin, discontinuous layer of yellowish material was present in the filter after retrieval. In one more case we observed a similar layer associated with a small solid yellowish fragment (lmm x 1 mm in size). In the latter three cases a slowing of flow of variable degree was fluoroscopically detectable after balloon inflation, due to the partial blockage of the pores of the filter membranes by the above described material. In the last case (see figure 2 ), the flow in the LCA. was completely blocked after bal-Ion inflation for dilation; after closing of the filter inside the sheath for retrieval, the flow was immediatly re-established. A considerable amount of debris was present inside the filter and was sent for histological evaluation, that showed fibrin mixed with aggregated platelets.
In another case the material was sent for histological evaluation with similar findings.
In all five cases, the clinical and morphologi-cal results of the procedure were totally successful, with a good lumen diameter restoration in all the vessels treated, without complaint of any, even very mild or transient, neurologic event in any phase of the procedure nor damage to the inner wall of the distal ICA after filter retrieval. Also the post-dilation angiographic evaluation of the intracranial circulation never showed, in comparison with the pre-P.T.A. findings, any modification related to distal embolization.
Discussion
Carotid stenosis due to atherosclerosis at the cervical bifurcation of the artery is known, when compared to atherosclerosis in other locations of the body, as related to friable, unstable and often ulcerated lesions 16.17 . This condition may be the cause of embolic brain complications during endovascular procedures 18. The symptomatic carotid plaques, according to the American Heart Association classification 19 , are type five, or fibroatheroma, consisting of multiple layers of lipid cores, cholesterol crystals, with interspersed smooth muscle cells and macrophages and a fibrous cap and type six, or complicated plaque, with disruption of the surface, usually due to intraplaque haemorrhage, with increased risk of embolization to the brain and intraluminal thrombosis. As a consequence, type six plaques are more frequently found in patients with ischemic neurological symptoms 20. Distal embolization during endovascular treatment may be due to the nonfibrous, pink, amorphous substance, mixed with cholesterol, contained in a type six plaque 21 or less likely to the fatty layers of a type five fibroatheroma. Of course, despite anti-cougulative medical therapy before and during treatment, embolization to the brain may also be due to thrombus, either floating thrombi already present on the surface of plaque ulcers or from coagulation provoked by the endovascular devices themselves.
The first protection systems developed for carotid angioplasty and stenting were of the occlusive type. In 1990, Theron et Al described a balloon brain protection system for angioplasty that was used in a large cohort (136 patients) with promising results 8. However, despite a general agreement on the principles of this protection procedure, it never obtained a wide dif-fusion since the triple coaxial system was too bulky for PTA and stenting and burdened by the need for a double passage through the stenosis (first the 2.6 F non-steerable catheter with the latex baloon attached on its tip by an elastic thread, second the guidewire for the stent and balloon catheter). The distal ICA protection required an average occlusion time of ten minutes, therefore the protection procedure was impossible in patients who did not tolerate carotid temporary occlusion. Similar problems are partially encountered with use of a more recent occlusion protection device 22, the Guardwire by PercuSurge we used in seven cases. The device is a guide wire consisting of a hollow nitinol tube with a built-in balloon, allowing a single passage through the stenosis with a 0.014" or 0.018" steerable wire. The balloon of the PercuSurge system remains inflated during stenting and PTA, then an aspiration catheteter is advanced over the wire for suction of possible debris. We never had any angiographic or neurological complication with this device, and also the degree of LCA. spasm seeemed less than that observed with filters. However, the occlusion time for the whole procedure was always longer than ten minutes. Therefore it is our present opinion that the occlusion should be limited only to the phase of the angioplasty balloon inflation, by far the most risky. Very small amounts of material were aspirated by the ad hoc catheter before deflation of the balloon. In comparison with the relatively large amounts of material captured by the filters we are describing, such condition might suggest either an incomplete aspiration (with consequent, even not detectable at angiography, distal embolization), partial escape of material in the external carotid artery (ECA) territory, or that the material found inside the filters is coagulation provoked by the device itself, probably by the micropores of the membrane.
Other cerebral protection methods described in the medical literature need the same occlusion in the carotid tree (lCA, common carotid (CCA) and/or ECA). KacheP reported a brain protection technique during carotid angioplasty and stenting by positioning an occlusive balloon proximal to the stenosis in the common carotid artery, presuming an inversion of flow from the ICA towards the external carotid artery; unfortunately, this event is not certain and collateral circulation may on the contrary be directed from the external to the internal carotid, thus nullifying the protective efficacy of the manoeuvre 13. Connors and Henry & Amor 24.11 described an occlusive method of cerebral protection with a double proximal CCA and distal ICA occlusion: also these techniques require crossing of the stenotic plaque with a balloon instead of a microguidewire 14,11 . The need for systems providing at the same time an emboli capture mechanism and carotid flow maintenance has led to the developement of filter protection devices 15,25 . The maintenance of ICA blood flow throughout the procedure is a theoretical advantage. There is no need to shorten the procedure due to the occlusion time with the risk of intolerance; there is consequently no need for hasty manoeuvres and both carotid flow and intracranial circulation can be checked at any time during the procedure. loon inflation for angioplasty; the filter membrane of the Angioguard system was almost entirely filled with solid thrombotic components (fibrin and aggregated platelets). In three other cases, a more or less evident but never marked or worrying slowing of flow was noted always after balloon inflation. In these three cases, the filters were filled with small amounts of material similar to that observed in the first one. In all the above mentioned cases, the filters underwent a prompt closure and retrieval and carotid flow was immediately restored. In the remaining case neither carotid flow reduction nor embolic material inside the filter after retrieval were detected. Future work and experience will elucidate where the material found inside the filters (much more frequently than after use of balloon protection systems) comes from: plaque core or surface, or coagulation activated by the stent, the dilation balloon or the filter membrane. The distal part of the guide wires in both systems showed good vessel tracking-ability in all patients. In one case (figure 3), the ICA could never be negotiated due to excessive tortuosity of its origin, associated with CCA kinking; thus, the origin of the ECA was occluded with a PercuSurge balloon and this manoeuvre allowed us to pass the ICA stenosis with the guidewire-filter device.
A current limit of both the AngioGuard and the Neuroshield systems is the 4.5 French size of the closed device to be inserted across the stenosis. A 4.5 French size corresponds to 1.5 mm. and consequently a residual lumen of the same size is desirable, for a safe crossing of the plaque, avoiding any dangerous friction. The diameter of the ICA varies between 5 and 7 mm, with a mean of 5.7 mm; this means that such a safe residual lumen can be found with a degree of stenosis of 79% (4.5 F filter device crossing a plaque in a 7 mm normal artery) or less. The choice of the filter size must be made very carefully after an attentive preliminary carotid lumen measurement, both at the level of the stenosis and distally, where the ICA regains a normal lumen. Trying to cross a tight stenosis with a device larger than the residual lumen may be very risky, with regard to possible fragments dislodgment, and this must definitely be avoided; an undersized filter open in the ICA could impair most of its debris capture capability, while an oversized one could damage the vessel wall or provoke excessive spasm. In the future devices with a thinner closed size (the one crossing the stenosis) are hoped for and expected to treat tighter stenoses in safer conditions.
The possible blood flow blockage by debris must be checked by intermittent dye injections and promptly recognized to allow correction by closure of the membrane and retrieval.
Conclusions
The use of these filters proved easy, reliable and fast, both in positioning and retrieving the device and in the behaviour like guide-wires for mounting the other endovascular devices (stent and balloon catheter).
Nevertheless, even with all these promising preliminary impressions, a very careful use is needed before the safety and efficacy of filters is confirmed in statistically significant series. Most important, the content of the filters must be analyzed, both in histological composition and in timing and features of formation in several cases to establish if it originates upstream or directly inside the filtering devices. Nevertheless, even in this last case, the condition could be acceptable (i.e., not risky and not invalidating the protecting action of the filter), or it might be counteracted pharmacologically.
The new filter devices for brain protection seem to open a new era for endovascular therapy of atherosclerotic carotid stenosis, allowing a general risk reduction even in patients with poor collateral cerebral circulation, along with a simple and effective placement technique. In our opinion, they deserve thorough evaluation in a wider series.
Note
In our more recent experience we were able to try the new metallic filter by Microvena (Trap@ ), which is characterized by a funnel-shaped basket for closing and retrieval of the filter. In this treatment, the filter, after stenting and balloon angioplasty, was half-filled with material which histologically proved to be pure fibrin filaments. No flow slowing was detected angiographically in any phase of the procedure and no clinical or morphological complications occurred. Positioning and retrieval of the system were less easy than with other devices, owing to the presence of the relatively bulky funnel basket.
